Results 231 to 240 of about 59,669 (311)

Risk of Serious Infections in Patients Treated With Biologic or Targeted‐synthetic Disease Modifying Antirheumatic Drugs in Qatar

open access: yesImmunity, Inflammation and Disease, Volume 13, Issue 4, April 2025.
This study investigates the risk of serious infections (SIs) in patients treated with biologic or targeted‐synthetic disease‐modifying antirheumatic drugs (b/tsDMARDs) in Qatar. Out of 1092 patients, 86 (7.9%) experienced SIs, with adalimumab and infliximab associated with higher SI rates.
Sreethish Sasi   +12 more
wiley   +1 more source

Promotion of Autophagy and Apoptosis in Colorectal Cancer Exposed to Imatinib and Thymoquinone

open access: yesJournal of Biochemical and Molecular Toxicology, Volume 39, Issue 4, April 2025.
The combination of IM and TQ induced autophagy in HCT116 cell line which in turn enhanced apoptosis. The combination inhibited colonies formation as well as the increments of various apoptotic markers. AMPK, when senses the rising autophagy, it will always activate apoptosis in a stress‐defense response.
Dalia El‐Khouly   +3 more
wiley   +1 more source

Antiphospholipid syndrome in pregnancy: a comprehensive literature review. [PDF]

open access: yesBMC Pregnancy Childbirth
Murvai VR   +8 more
europepmc   +1 more source

Systemic Inflammatory Diseases in Children With Sickle Cell Disease: A French Multicenter Observational Study on Diagnostic and Therapeutic Issues

open access: yesPediatric Blood &Cancer, Volume 72, Issue 4, April 2025.
ABSTRACT Background Systemic inflammatory diseases (SIDs) have been reported in patients with sickle cell disease (SCD), but clinical data in children are scarce. Objectives To identify clinical and laboratory features at diagnosis of SID in children with SCD and to describe their evolution.
Caroline Vinit   +19 more
wiley   +1 more source

Pediatric Pulmonology 2024 Year in Review: Rare and Diffuse Lung Disease

open access: yesPediatric Pulmonology, Volume 60, Issue 4, April 2025.
ABSTRACT The field of pediatric rare and diffuse lung diseases continues to advance, with ongoing research deepening our understanding of the diagnosis and treatment of conditions such as children's interstitial and diffuse lung disease (chILD), non‐cystic fibrosis (CF) bronchiectasis, and pulmonary complications of childhood cancer.
Pi Chun Cheng   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy